A detailed history of Core Wealth Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Core Wealth Advisors, Inc. holds 182 shares of NVO stock, worth $25,911. This represents 0.01% of its overall portfolio holdings.

Number of Shares
182
Previous 182 -0.0%
Holding current value
$25,911
Previous $18,000 27.78%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $15,975 - $19,191
182 New
182 $18,000
Q2 2020

Jul 31, 2020

SELL
$58.54 - $67.94 $4,273 - $4,959
-73 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$49.46 - $64.78 $3,610 - $4,728
73 New
73 $4,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Core Wealth Advisors, Inc. Portfolio

Follow Core Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Core Wealth Advisors, Inc. with notifications on news.